On August 26, the 13th Standing Committee of the National People’s Congress voted to adopt the amendment of the Drug Administration Law of the People’s Republic of China. The newly revised Drug Administration Law will come into force on December 1, 2019. To implement the system of drug market licenser, the holder of drug market license shall be responsible for the safety, effectiveness and quality reliability of drugs in the whole process of drug development, production, operation and use according to law. To strengthen the information requirements for the whole process of drugs and strictly manage the links of drugRead More →
Thank you for your interests/registration! For complete and full access to our platform, please contact us to subscribe as a paid-up member. The annual fee is $5,500 Best! Paolo yue Email: yuefeng7832@hotmail.com Cell: 008613501397114